Advanz Pharma Corp. buy melinda
Start price
15.08.17
/
50%
€346.37
Target price
19.12.17
€405.90
Performance (%)
-45.31%
End price
19.12.17
€189.42
Summary
This prediction ended on 19.12.17 with a price of €189.42. Massive losses of -45.31% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Advanz Pharma Corp. | - | - | - | - |
| iShares Core DAX® | -1,76 % | 1,67 % | 2,10 % | 51,75 % |
| iShares Nasdaq 100 | 2,32 % | 12,78 % | 38,81 % | 96,06 % |
| iShares Nikkei 225® | 5,02 % | 13,30 % | 60,10 % | 71,80 % |
| iShares S&P 500 | 0,80 % | 6,20 % | 25,36 % | 68,52 % |
Comments by melinda for this prediction
In the thread Advanz Pharma Corp diskutieren
zu folgen
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Advanz Pharma Corp.
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€384.00
15.08.17
15.08.17
€450.00
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€2,570.4
12.08.16
12.08.16
€3,264.0
13.02.17
13.02.17
-74.52%
13.02.17
13.02.17


